Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic SystfiledCriticalInhale Therapeutic Syst
Publication of NZ299241ApublicationCriticalpatent/NZ299241A/en
The specification describes the pulsatile systemic delivery of parathyroid hormone and its use in the treatment of osteoporosis. The preferred PTH concentration range is from 1mg/ml to 20mg/ml.
NZ299241A1992-09-291996-08-27Systemic delivery of parathyroid hormone by oral inhalation
NZ299241A
(en)